Patient Characteristics Associated With Outcomes of COVID-19 Infection in Gabon | Cardiology | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Demographic and Clinical Characteristics Associated With Severity, Clinical Outcomes, and Mortality of COVID-19 Infection in Gabon

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME
Key Points

Question  What were the epidemiologic and clinical aspects of patients with COVID-19 infection in the Armed Forces Hospital in Libreville, Gabon, from March to June 2020?

Findings  In this cross-sectional study of 837 patients with COVID-19 in Gabon, 63% had no symptoms. Severity of disease and mortality were associated with advanced age and advanced stage of lung damage.

Meaning  Findings from this observational study provide preliminary data for use in future epidemiologic studies of COVID-19 in Gabon.

Abstract

Importance  Since the emergence of COVID-19 in central China, sub-Saharan African countries, with the exception of South Africa, have been relatively spared during the COVID-19 pandemic. Consequently, few descriptive studies from this region are available.

Objective  To describe the clinical characteristics and outcomes of patients with COVID-19 infection in Gabon, from March to June 2020.

Design, Setting, and Participants  A single-center, cross-sectional study of 837 patients with COVID-19 was conducted from March to June 2020 in the Armed Forces Hospital in Libreville, Gabon.

Main Outcomes and Measures  Demographic and clinical characteristics and imaging findings of hospitalized patients with COVID-19.

Results  Of the 837 patients enrolled, 572 (68.3%) were men, and 264 (31.5%) were women (male to female ratio, 2:1); the median (interquartile range [IQR]) age was 35 (30-45) years (mean [SD] age, 38.0 [12.2] years. The mortality rate associated with COVID-19 was low (1.4%). Of these 837 patients, 524 (62.6%) were categorized as having no symptoms, 282 (33.7%) as having mild symptoms, and 31 (3.7%) as having severe symptoms. Patients with severe symptoms were older (mean [SD] age, 46.1 [14.7] years) than patients with mild symptoms (mean [SD] age, 41.3 [12.5] years) and those with no symptoms (mean [SD] age, 35.7 [11.3] years) (Kruskal-Wallis χ22 = 53.5; P < .001). History of diabetes was the principal risk factor associated with both severe symptoms in 5 of 31 patients (16.1%) and mild symptoms in 11 of 282 (3.9%) compared with no symptoms in 5 of 524 (0.9%) (Pearson χ22 = 30.9; P < .001). Patients with severe symptoms and a fatal outcome were older (mean [SD] age, 53.4 [15.1] years) than survivors (mean [SD] age, 41.5 [12.9] years) (t20.83 = 2.2; P = .03).

Conclusions and Relevance  In this single-center, cross-sectional study in Libreville, Gabon, the mortality rate associated with COVID-19 infection from March to June 2020 was low, and patients who died of COVID-19 infection were younger on average than reported elsewhere, possibly reflecting a smaller elderly population in Gabon.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Accepted for Publication: June 29, 2021.

Published: September 14, 2021. doi:10.1001/jamanetworkopen.2021.24190

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Iroungou BA et al. JAMA Network Open.

Corresponding Author: Berthe Amélie Iroungou, PhD, Unité Mixte de Recherche Centre International de Recherches Médicales de Franceville et le Service de Santé Militaire, PO Box 20404 HIAOBO, Libreville, Gabon (abertheamelie@gmail.com).

Author Contributions: Dr Iroungou had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Iroungou, Mangouka, Bivigou-Mboumba, Nzigou Boucka, Aghokeng, Tchoua, Pineau, Nzenze.

Acquisition, analysis, or interpretation of data: Iroungou, Mangouka, Bivigou-Mboumba, Moussavou-Boundzanga, Obame-Nkoghe, Nzigou Boucka, Mouinga-Ondeme, Nzenze.

Drafting of the manuscript: Iroungou, Mangouka, Bivigou-Mboumba, Nzigou Boucka, Mouinga-Ondeme, Pineau.

Critical revision of the manuscript for important intellectual content: Iroungou, Mangouka, Bivigou-Mboumba, Moussavou-Boundzanga, Obame-Nkoghe, Aghokeng, Tchoua, Nzenze.

Statistical analysis: Mangouka, Moussavou-Boundzanga, Obame-Nkoghe, Nzigou Boucka, Aghokeng, Pineau.

Obtained funding: Iroungou, Tchoua, Nzenze.

Administrative, technical, or material support: Iroungou, Bivigou-Mboumba, Nzenze.

Supervision: Iroungou, Bivigou-Mboumba.

Conflict of Interest Disclosures: None reported.

Funding/Support: This work was supported by the Gabonese government (Prof Tchoua and Prof Nzenze).

Role of the Funder/Sponsor: The Gabonese government had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Additional Contributions: We are grateful to all patients involved in this study. We also acknowledge Remi Charlebois, MS (GSSHealth), for attentive review of the manuscript. He was not paid for this contribution.

References
1.
Bogoch  II , Watts  A , Thomas-Bachli  A , Huber  C , Kraemer  MUG , Khan  K .  Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel.   J Travel Med. 2020;27(2):taaa008. doi:10.1093/jtm/taaa008PubMedGoogle Scholar
2.
Zhu  J , Zhong  Z , Ji  P ,  et al.  Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis.   Fam Med Community Health. 2020;8(2):e000406. doi:10.1136/fmch-2020-000406 PubMedGoogle Scholar
3.
Huang  C , Wang  Y , Li  X ,  et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.   Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5 PubMedGoogle ScholarCrossref
4.
Guo  T , Fan  Y , Chen  M ,  et al.  Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).   JAMA Cardiol. 2020;5(7):811-818. doi:10.1001/jamacardio.2020.1017 PubMedGoogle ScholarCrossref
5.
Zhou  F , Yu  T , Du  R ,  et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.   Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3 PubMedGoogle ScholarCrossref
6.
Abduljalil  JM , Abduljalil  BM .  Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view.   New Microbes New Infect. 2020;35:100672. doi:10.1016/j.nmni.2020.100672 PubMedGoogle Scholar
7.
Okeahalam  C , Williams  V , Otwombe  K .  Factors associated with COVID-19 infections and mortality in Africa: a cross-sectional study using publicly available data.   BMJ Open. 2020;10(11):e042750. doi:10.1136/bmjopen-2020-042750 PubMedGoogle Scholar
8.
Mveang Nzoghe  A , Essone  PN , Leboueny  M ,  et al.  Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2.   Immun Inflamm Dis. 2021;9(1)128-133. doi:10.1002/iid3.367PubMedGoogle Scholar
9.
Republique Gabonaise. Projet reponse d'urgence COVID-19: plan d’engagement des parties prenantes (PEPP). Accessed June 18, 2021. https://documents1.worldbank.org/curated/en/220291588188259865/text/Stakeholder-Engagement-Plan-SEP-GABON-COVID-19-Strategic-Preparedness-and-Response-Project-SPRP-P173927.txt
10.
Li  K , Wu  J , Wu  F ,  et al.  The clinical and chest CT features associated with severe and critical COVID-19 pneumonia.   Invest Radiol. 2020;55(6):327-331. doi:10.1097/RLI.0000000000000672 PubMedGoogle ScholarCrossref
11.
Hochberg  Y .  A sharper Bonferroni procedure for multiple tests of significance.   Biometrika. 1988;75(4):800-802. doi:10.1093/biomet/75.4.800 Google ScholarCrossref
12.
Njenga  MK , Dawa  J , Nanyingi  M ,  et al.  Why is there low morbidity and mortality of COVID-19 in Africa?   Am J Trop Med Hyg. 2020;103(2):564-569. doi:10.4269/ajtmh.20-0474 PubMedGoogle ScholarCrossref
13.
Bowale  A , Abayomi  A , Idris  J ,  et al.  Clinical presentation, case management and outcomes for the first 32 COVID-19 patients in Nigeria.   Pan Afr Med J. 2020;35(suppl 2):24. doi:10.11604/pamj.supp.2020.35.2.23262 PubMedGoogle ScholarCrossref
14.
Du  Y , Tu  L , Zhu  P ,  et al.  Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study.   Am J Respir Crit Care Med. 2020;201(11):1372-1379. doi:10.1164/rccm.202003-0543OC PubMedGoogle ScholarCrossref
15.
Liang  WH , Guan  WJ , Li  CC ,  et al.  Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.   Eur Respir J. 2020;55:2000562. doi:10.1183/13993003.00562-2020 Google Scholar
16.
Capuano  A , Rossi  F , Paolisso  G .  COVID-19 kills more men than women: an overview of possible reasons.   Front Cardiovasc Med. 2020;7:131. doi:10.3389/fcvm.2020.00131 PubMedGoogle ScholarCrossref
17.
Otuonye  NM , Olumade  TJ , Ojetunde  MM ,  et al.  Clinical and demographic characteristics of COVID-19 patients in Lagos, Nigeria: a descriptive study.   J Natl Med Assoc. 2021;113(3):301-306. doi:10.1016/j.jnma.2020.11.011PubMedGoogle ScholarCrossref
18.
Channappanavar  R , Fett  C , Mack  M , Ten Eyck  PP , Meyerholz  DK , Perlman  S .  Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection.   J Immunol. 2017;198(10):4046-4053. doi:10.4049/jimmunol.1601896 PubMedGoogle ScholarCrossref
19.
Centers for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). COVID-19 dashboard. Accessed September 13, 2020. https://gisanddata.maps.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6
20.
Wu  C , Chen  X , Cai  Y ,  et al.  Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.   JAMA Intern Med. 2020;180(7):934-943. doi:10.1001/jamainternmed.2020.0994 PubMedGoogle ScholarCrossref
21.
Nikpouraghdam  M , Jalali Farahani  A , Alishiri  G ,  et al.  Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in Iran: a single center study.   J Clin Virol. 2020;127:104378. doi:10.1016/j.jcv.2020.104378 PubMedGoogle Scholar
22.
Iaccarino  G , Grassi  G , Borghi  C , Ferri  C , Salvetti  M , Volpe  M ; SARS-RAS Investigators.  Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension.   Hypertension. 2020;76(2):366-372. doi:10.1161/HYPERTENSIONAHA.120.15324 PubMedGoogle ScholarCrossref
23.
Gayam  V , Chobufo  MD , Merghani  MA , Lamichanne  S , Garlapati  PR , Adler  MK .  Clinical characteristics and predictors of mortality in African-Americans with COVID-19 from an inner-city community teaching hospital in New York.   J Med Virol. 2021;93(2):812-819. doi:10.1002/jmv.26306 Google ScholarCrossref
24.
Boulle  A , Davies  MA , Hussey  H ,  et al.  Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa.   Clin Infect Dis. Published online August 29, 2020. doi:10.1093/cid/ciaa1198PubMedGoogle Scholar
25.
Meftahi  GH , Jangravi  Z , Sahraei  H , Bahari  Z .  The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging”.   Inflamm Res. 2020;69(9):825-839. doi:10.1007/s00011-020-01372-8 Google ScholarCrossref
26.
Pontone  G , Scafuri  S , Mancini  M ,  et al.  Role of computed tomography in COVID-19.   J Cardiovasc Comput Tomogr. 2021;15(1):27-36. doi:10.1016/j.jcct.2020.08.013 Google ScholarCrossref
27.
Gaye  B , Khoury  S , Cene  CW ,  et al.  Socio-demographic and epidemiological consideration of Africa’s COVID-19 response: what is the possible pandemic course?   Nat Med. 2020;26(7):996-999. doi:10.1038/s41591-020-0960-y PubMedGoogle ScholarCrossref
28.
Nachega  J , Seydi  M , Zumla  A .  The late arrival of coronavirus disease 2019 (COVID-19) in Africa: mitigating pan-continental spread.   Clin Infect Dis. 2020;71(15):875-878. doi:10.1093/cid/ciaa353 Google ScholarCrossref
29.
Diop  BZ , Ngom  M , Pougué Biyong  C , Pougué Biyong  JN .  The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: a modelling study.   BMJ Glob Health. 2020;5(5):e002699. doi:10.1136/bmjgh-2020-002699 PubMedGoogle Scholar
30.
Lone  SA , Ahmad  A .  COVID-19 pandemic - an African perspective.   Emerg Microbes Infect. 2020;9(1):1300-1308. doi:10.1080/22221751.2020.1775132 PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close